Gene: CCDC113
Official Full Name: cilia and flagella associated protein 263provided by HGNC
Gene Summary: Involved in cilium assembly. Located in centriolar satellite and ciliary basal body. Part of protein-containing complex. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO27200 | CCDC113 Knockout cell line (HeLa) | Human | CCDC113 | 1:3~1:6 | Negative | Online Inquiry |
KO27201 | CCDC113 Knockout cell line (HCT 116) | Human | CCDC113 | 1:2~1:4 | Negative | Online Inquiry |
KO27202 | CCDC113 Knockout cell line (HEK293) | Human | CCDC113 | 1:3~1:6 | Negative | Online Inquiry |
KO27203 | CCDC113 Knockout cell line (A549) | Human | CCDC113 | 1:3~1:4 | Negative | Online Inquiry |
CCDC113 Gene Knockout Cell Lines are a sophisticated biological research tool designed to facilitate the study of the CCDC113 gene's function and its role in cellular processes. These knockout cell lines are created using advanced CRISPR/Cas9 gene-editing technology, effectively rendering the CCDC113 gene inactive. This targeted approach allows researchers to investigate the phenotypic effects resulting from the loss of this gene, providing key insights into its potential involvement in cellular mechanisms like cell cycle regulation, differentiation, and response to stress, which are crucial for understanding various pathological conditions.
The primary function of CCDC113 gene knockout cell lines lies in their ability to model diseases associated with the dysregulation of this gene. By studying the altered behavior of these cells in vitro, scientists can elucidate the underlying molecular pathways and identify new therapeutic targets for diseases such as cancer, genetic disorders, or neurodegenerative diseases. This significant application in both research and clinical settings underscores the relevance of this product in advancing our understanding of complex biological systems and contributing to the development of innovative treatments.
One of the standout advantages of CCDC113 gene knockout cell lines is their ease of use, reproducibility, and specificity compared to other genomic manipulation methods. Unlike traditional methods such as RNA interference that may generate off-target effects, these knockout lines provide a clean genetic model that allows for precise functional studies. Additionally, the availability of these specific cell lines means that researchers can save valuable time and resources, expediting their experimental timelines and enhancing productivity.
For researchers and clinicians focused on elucidating gene functions and their implications in disease, purchasing CCDC113 gene knockout cell lines represents a powerful investment. The capacity to create robust, reliable, and targeted experimental models facilitates better hypothesis generation and testing. As a company with a long-standing commitment to advancing scientific research through innovative solutions, we offer these knockout cell lines with the assurance of rigorous quality control and a deep understanding of the scientific landscape, enabling customers to achieve meaningful results in their work.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.